PE20061301A1 - 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos - Google Patents
7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianosInfo
- Publication number
- PE20061301A1 PE20061301A1 PE2006000363A PE2006000363A PE20061301A1 PE 20061301 A1 PE20061301 A1 PE 20061301A1 PE 2006000363 A PE2006000363 A PE 2006000363A PE 2006000363 A PE2006000363 A PE 2006000363A PE 20061301 A1 PE20061301 A1 PE 20061301A1
- Authority
- PE
- Peru
- Prior art keywords
- oxo
- indol
- dihydro
- fluoro
- oxazolidin
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 150000004702 methyl esters Chemical class 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical group [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical group C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- XSGHLZBESSREDT-UHFFFAOYSA-N methylenecyclopropane Chemical group C=C1CC1 XSGHLZBESSREDT-UHFFFAOYSA-N 0.000 abstract 1
- 229960000649 oxyphenbutazone Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66871505P | 2005-04-06 | 2005-04-06 | |
| US68403305P | 2005-05-24 | 2005-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061301A1 true PE20061301A1 (es) | 2007-02-09 |
Family
ID=36636389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000363A PE20061301A1 (es) | 2005-04-06 | 2006-04-04 | 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7435751B2 (enExample) |
| EP (1) | EP1869030A1 (enExample) |
| JP (1) | JP2008534672A (enExample) |
| KR (1) | KR20070108938A (enExample) |
| AP (1) | AP2007004172A0 (enExample) |
| AR (1) | AR053839A1 (enExample) |
| AU (1) | AU2006231919A1 (enExample) |
| BR (1) | BRPI0610533A2 (enExample) |
| CA (1) | CA2603899A1 (enExample) |
| CR (1) | CR9417A (enExample) |
| DO (1) | DOP2006000080A (enExample) |
| GT (1) | GT200600133A (enExample) |
| IL (1) | IL186119A0 (enExample) |
| MX (1) | MX2007012386A (enExample) |
| NL (1) | NL1031525C2 (enExample) |
| NO (1) | NO20075505L (enExample) |
| PE (1) | PE20061301A1 (enExample) |
| TN (1) | TNSN07373A1 (enExample) |
| TW (1) | TW200716101A (enExample) |
| UY (1) | UY29452A1 (enExample) |
| WO (1) | WO2006106427A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1781643A1 (en) * | 2004-08-06 | 2007-05-09 | Pharmacia & Upjohn Company LLC | Oxindole oxazolidinones as antibacterial agents |
| KR100891485B1 (ko) | 2007-10-29 | 2009-04-02 | 주식회사 만도 | 디스크 브레이크의 주차브레이크 장치 |
| US20090124737A1 (en) * | 2007-11-12 | 2009-05-14 | Eastman Chemical Company | Acrylic plastisol viscosity reducers |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164510A (en) | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| ATE112773T1 (de) | 1988-09-15 | 1994-10-15 | Upjohn Co | 5-indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(nitrogen- substituierte)phenyl-5-beta-amidomethyloxazolid n-2-one. |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| US6015429A (en) * | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| DE19649095A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue Heteroaryl-Oxazolidinone |
| CN1288462A (zh) | 1998-01-23 | 2001-03-21 | 法玛西雅厄普约翰美国公司 | 噁唑烷酮组合库、组合物和制备方法 |
| CN1301248A (zh) | 1998-04-14 | 2001-06-27 | 三星精密化学株式会社 | 手性(s)－2,3－二取代－1－丙胺衍生物的制备方法 |
| AU1379900A (en) | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel substituted phenyloxazolidone derivatives |
| AU764980B2 (en) | 1998-11-27 | 2003-09-04 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| JP2003501351A (ja) | 1999-05-27 | 2003-01-14 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌剤としての二環系オキサゾリジノン |
| ATE321024T1 (de) | 2000-10-17 | 2006-04-15 | Pharmacia & Upjohn Co Llc | Verfahren zur herstellung von oxazolidinonverbindungen |
| ES2268011T3 (es) | 2001-04-07 | 2007-03-16 | Astrazeneca Ab | Oxazolidinonas que contienen un grupo sulfonimida como antibioticos. |
| EP1380121B1 (en) | 2001-04-20 | 2007-09-26 | Pharmacia & Upjohn Company LLC | Process to prepare oxazolidinones |
| AR038536A1 (es) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
| EP1781643A1 (en) * | 2004-08-06 | 2007-05-09 | Pharmacia & Upjohn Company LLC | Oxindole oxazolidinones as antibacterial agents |
-
2006
- 2006-03-26 AU AU2006231919A patent/AU2006231919A1/en not_active Abandoned
- 2006-03-27 AP AP2007004172A patent/AP2007004172A0/xx unknown
- 2006-03-27 BR BRPI0610533-5A patent/BRPI0610533A2/pt not_active Application Discontinuation
- 2006-03-27 MX MX2007012386A patent/MX2007012386A/es unknown
- 2006-03-27 CA CA002603899A patent/CA2603899A1/en not_active Abandoned
- 2006-03-27 JP JP2008504870A patent/JP2008534672A/ja not_active Withdrawn
- 2006-03-27 EP EP06727519A patent/EP1869030A1/en not_active Withdrawn
- 2006-03-27 KR KR1020077022657A patent/KR20070108938A/ko not_active Ceased
- 2006-03-27 WO PCT/IB2006/000954 patent/WO2006106427A1/en not_active Ceased
- 2006-03-30 US US11/393,961 patent/US7435751B2/en not_active Expired - Fee Related
- 2006-04-04 TW TW095112018A patent/TW200716101A/zh unknown
- 2006-04-04 PE PE2006000363A patent/PE20061301A1/es not_active Application Discontinuation
- 2006-04-04 UY UY29452A patent/UY29452A1/es not_active Application Discontinuation
- 2006-04-04 AR ARP060101328A patent/AR053839A1/es unknown
- 2006-04-05 GT GT200600133A patent/GT200600133A/es unknown
- 2006-04-05 DO DO2006000080A patent/DOP2006000080A/es unknown
- 2006-04-05 NL NL1031525A patent/NL1031525C2/nl not_active IP Right Cessation
-
2007
- 2007-09-20 IL IL186119A patent/IL186119A0/en unknown
- 2007-10-05 CR CR9417A patent/CR9417A/es unknown
- 2007-10-05 TN TNP2007000373A patent/TNSN07373A1/fr unknown
- 2007-10-31 NO NO20075505A patent/NO20075505L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1869030A1 (en) | 2007-12-26 |
| JP2008534672A (ja) | 2008-08-28 |
| TNSN07373A1 (fr) | 2009-03-17 |
| AR053839A1 (es) | 2007-05-23 |
| IL186119A0 (en) | 2008-01-20 |
| NL1031525C2 (nl) | 2007-01-30 |
| UY29452A1 (es) | 2006-11-30 |
| NL1031525A1 (nl) | 2006-10-09 |
| GT200600133A (es) | 2006-11-29 |
| DOP2006000080A (es) | 2006-12-15 |
| US7435751B2 (en) | 2008-10-14 |
| NO20075505L (no) | 2007-10-31 |
| AU2006231919A1 (en) | 2006-10-12 |
| BRPI0610533A2 (pt) | 2010-06-29 |
| KR20070108938A (ko) | 2007-11-13 |
| TW200716101A (en) | 2007-05-01 |
| WO2006106427A8 (en) | 2007-12-06 |
| US20060229349A1 (en) | 2006-10-12 |
| CA2603899A1 (en) | 2006-10-12 |
| CR9417A (es) | 2007-12-04 |
| WO2006106427A1 (en) | 2006-10-12 |
| MX2007012386A (es) | 2007-11-07 |
| AP2007004172A0 (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20130525A1 (es) | Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
| PE20141228A1 (es) | Derivados de pirrolopirimidina y purina | |
| PE20141907A1 (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de accion sistemica, metodos y usos de las mismas | |
| TN2009000199A1 (en) | Heteromonocyclic compound and use thereof | |
| PE20131117A1 (es) | Derivados de bencimidazol como inhibidores de prostaglandinas | |
| PE20090695A1 (es) | Derivados de pirimidindiona como agonistas del receptor de acido nicotinico | |
| PE20121474A1 (es) | Nuevos compuestos de espiropiperidina | |
| PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
| PE20070720A1 (es) | Derivados de fenilo como antagonistas del receptor 3 de la histamina | |
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| PE20121522A1 (es) | Derivados de acido 5-alquinil-3-amida-2-tiofeno-carboxilico como inhibidores del virus flaviviridae | |
| PE20170949A1 (es) | Espiroindolinas para el tratamiento y profilaxis de infeccion por virus respiratorio sincitial (rsv) | |
| NO20092539L (no) | Antibakterielle kinolin-derivater | |
| AR053561A1 (es) | Compuestos novedosos, isomeros de los mismos o las sales farmaceuticamente aceptables de los mismos como el antagonista del receptor vaniloide y las composiciones farmaceuticas que contienen los mismos | |
| PE20080283A1 (es) | Profarmacos antimicrobianos de oxazolidinona | |
| AR054608A1 (es) | Derivados de oxazolidinona enlazados a quinolonas como antibacterianos | |
| PE20080207A1 (es) | DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5 | |
| JO2725B1 (en) | Quinoline antibacterial derivatives | |
| PE20061301A1 (es) | 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos | |
| RU2011145052A (ru) | Производные 2-гидроксиэтил-1н-хинолин-2-она и их азаизостерические аналоги с антибактериальной активностью | |
| PE20090106A1 (es) | Derivados de eritromicina como agentes antibacterianos | |
| PE20070010A1 (es) | Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d | |
| EA200970536A1 (ru) | Антибактериальные хинолиновые производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |